Pasar al contenido principal

CARACTERIZACION FUNCIONAL DE DOMINIOS MESOSCOPICOS DE SUPERFICIE ENDOTELIAL REGULADOS POR LA SUBFAMILIA RHOA DE GTPASAS DURANTE LA RESPUESTA INFLAMATORIA

PID2020-119881RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin

  • Cacho Navas, Cristina
  • López Pujante, Carmen
  • Reglero Real, Natalia
  • Colás Algora, Natalia
  • Cuervo, Ana
  • Conesa, Jose Javier
  • Barroso, Susana
  • de Rivas, Gema
  • Ciordia, Sergio
  • Paradela, Alberto
  • D'Agostino, Gianluca
  • Manzo, Carlo
  • Feito, Jorge
  • Andrés, Germán
  • Molina Jiménez, Francisca
  • Majano Rodríguez, Pedro Lorenzo
  • Correas, Isabel
  • Carazo, José Maria
  • Nourshargh, Sussan
  • Huch, Meritxell
  • Millán, Jaime
Epithelial intercellular adhesion molecule (ICAM)-1 is apically polarized, interacts with, and guides leukocytes across epithelial barriers. Polarized hepatic epithelia organize their apical membrane domain into bile canaliculi and ducts, which are not accessible to circulating immune cells but that nevertheless confine most of ICAM-1. Here, by analyzing ICAM-1_KO human hepatic cells, liver organoids from ICAM-1_KO mice and rescue-of-function experiments, we show that ICAM-1 regulates epithelial apicobasal polarity in a leukocyte adhesion-independent manner. ICAM-1 signals to an actomyosin network at the base of canalicular microvilli, thereby controlling the dynamics and size of bile canalicular-like structures. We identified the scaffolding protein EBP50/NHERF1/SLC9A3R1, which connects membrane proteins with the underlying actin cytoskeleton, in the proximity interactome of ICAM-1. EBP50 and ICAM-1 form nano-scale domains that overlap in microvilli, from which ICAM-1 regulates EBP50 nano-organization. Indeed, EBP50 expression is required for ICAM-1-mediated control of BC morphogenesis and actomyosin. Our findings indicate that ICAM-1 regulates the dynamics of epithelial apical membrane domains beyond its role as a heterotypic cell–cell adhesion molecule and reveal potential therapeutic strategies for preserving epithelial architecture during inflammatory stress.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Harnessing homeostatically active RhoC at cell junctions preserves human endothelial barrier function during inflammation

  • Colás-Algora, Natalia
  • Muñoz-Pinillos, Pablo
  • Barroso, Susana
  • Cacho-Navas, Cristina
  • Caballero, Álvaro
  • Cerro-Tello, Gema
  • Rivas, Gema de
  • González-Fernández, Martin
  • Jimenez-Alfaro, Ignacio
  • Fresno, Manuel
  • Ribas, Catalina
  • Paradela, Alberto
  • López-Collazo, Eduardo
  • Fernández, José-Jesús
  • Millán, Jaime
The GTPase RhoA plays a critical role in generating actomyosin-mediated contractile forces that cause endothelial hyperpermeability during systemic inflammatory diseases. RhoA is almost identical to RhoB and RhoC, all of which are molecular targets of specific bacterial toxins. Searching for new treatments to modulate Rho-dependent endothelial integrity, we demonstrate that the selective and simultaneous activation of these three Rho GTPases with a chimeric recombinant toxin does not induce cell contraction but enhances microvascular endothelial barrier function in response to pathological inflammatory challenges in vitro and in vivo. This pro-barrier effect is specifically mediated by RhoC, whose activity is increased by cell confluence. The uniqueness of RhoC relies on an arginine residue (R188) within its hypervariable region that determines its junctional localization, high homeostatic activity, and barrier-protective function, in contrast to the permeability-inducing, low homeostatic activity of RhoA and RhoB. Quantitative proteomics and high-resolution confocal microscopy revealed that RhoC regulates perijunctional actomyosin and the expression of myosin light chain proteins. Thus, harnessing the activity of RhoC represents a potential therapy for strengthening endothelial barriers during pathological inflammation., The expert technical advices of the confocal microscopy, electron microscopy, genomic and animal facilities are gratefully acknowledged. The work was supported by grants PID2020-119881RB-I00 from AEI (to CC-N, PM-P, NC-A, SB, GdR, GC-T, and JM) and Grant TomoXliver2, Ref: S2022/BMD-7232 funded by Comunidad Autónoma de Madrid. (to SB and JM), and IND2019/BMD-17139 (to GC-T and JM) from Comunidad de Madrid. This research work was also funded by the European Commission─NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global) (to JM). SB is also supported by Endocornea2, Convenio Colaboración CSIC, funded by Instituto de Investigación Fundación Jiménez Díaz. The authors also thank Dr Phil Mason, who provided English language support., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids

  • Blázquez-García, Irene
  • Guerrero, Laura
  • Cacho-Navas, Cristina
  • Djouder, Nabil
  • Millan, Jaime
  • Paradela, Alberto
  • Carmona-Rodríguez, Lorena
  • Corrales, Fernando J.
MDR3 (multidrug resistance 3) deficiency in humans (MDR2 in mice) causes progressive familial intrahepatic cholestasis type 3 (PFIC3). PFIC3 is a lethal disease characterized by an early onset of intrahepatic cholestasis progressing to liver cirrhosis, a preneoplastic condition, putting individuals at risk of hepatocellular carcinoma (HCC). Hepatocyte-like organoids from MDR2-deficient mice (MDR2KO) were used in this work to study the molecular alterations caused by the deficiency of this transporter. Proteomic analysis by mass spectrometry allowed characterization of 279 proteins that were differentially expressed in MDR2KO compared with wild-type organoids. Functional enrichment analysis indicated alterations in three main cellular functions: (1) interaction with the extracellular matrix, (2) remodeling intermediary metabolism, and (3) cell proliferation and differentiation. The affected cellular processes were validated by orthogonal molecular biology techniques. Our results point to molecular mechanisms associated with PFIC3 that may drive the progression to liver cirrhosis and HCC and suggest proteins and cellular processes that could be targeted for the development of early detection strategies for these severe liver diseases., The CNB was supported by Comunidad de Madrid Grants B2017/BMD-3817 and 2022/BMD-7232. Severo Ochoa Project SEV 2017-0712. Intramural CSIC PIE/COVID-19 projects 202020E079 and 202020E108. MICIN PID2021- 127496NB-100 (F.J.C.) and PID2020-119881RB-I00 (J.M). This research work was also funded by the European Commission�NextGenerationEU (Regulation EU 2020/ 2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Simultaneous Targeting of IL-1-Signaling and IL-6-Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm-Brief Report

  • Colás-Algora, Natalia
  • Muñoz-Pinillos, Pablo
  • Cacho-Navas, Cristina
  • Avendaño-Ortiz, José
  • Rivas, Gema de
  • Barroso, Susana
  • López-Collazo, Eduardo
  • Millán, Jaime
Systemic inflammatory diseases, such as sepsis and severe COVID-19, provoke acute respiratory distress syndrome in which the pathological hyperpermeability of the microvasculature, induced by uncontrolled inflammatory stimulation, causes pulmonary edema. Identifying the inflammatory mediators that induce human lung microvascular endothelial cell barrier dysfunction is essential to find the best anti-inflammatory treatments for critically ill acute respiratory distress syndrome patients., This research work was funded by the European Commission – NextGenerationEU (Regulation EU [European Union] 2020/2094), through CSIC’s (Consejo Superior de Investigaciones Científicas) Global Health Platform (PTI [Plataforma Temática Interdisciplinar] Salud Global), PID2020-119881RB-I00 from Spanish Ministry of Science and P2022/BMD-7232 TomoXliver 2 (to J. Millán). N. Colás-Algora is a recipient of an FPU (Formación Profesorado Universitario) fellowship from the Ministry of Education., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells

  • Cacho-Navas, Cristina
  • Reglero-Real, Natalia
  • Colás-Algora, Natalia
  • Barroso, Susana
  • de Rivas, Gema
  • Stamatakis, Kostantinos
  • Feito, Jorge
  • Andrés, Germán
  • Fresno, Manuel
  • Kremer, Leonor
  • Correas, Isabel
  • Alonso, Miguel A.
  • Millán, Jaime
Apical localization of Intercellular Adhesion Receptor (ICAM)-1 regulates the adhesion and guidance of leukocytes across polarized epithelial barriers. Here, we investigate the molecular mechanisms that determine ICAM-1 localization into apical membrane domains of polarized hepatic epithelial cells, and their effect on lymphocyte-hepatic epithelial cell interaction. We had previously shown that segregation of ICAM-1 into apical membrane domains, which form bile canaliculi and bile ducts in hepatic epithelial cells, requires basolateral-to-apical transcytosis. Searching for protein machinery potentially involved in ICAM-1 polarization we found that the SNARE-associated protein plasmolipin (PLLP) is expressed in the subapical compartment of hepatic epithelial cells in vitro and in vivo. BioID analysis of ICAM-1 revealed proximal interaction between this adhesion receptor and PLLP. ICAM-1 colocalized and interacted with PLLP during the transcytosis of the receptor. PLLP gene editing and silencing increased the basolateral localization and reduced the apical confinement of ICAM-1 without affecting apicobasal polarity of hepatic epithelial cells, indicating that ICAM-1 transcytosis is specifically impaired in the absence of PLLP. Importantly, PLLP depletion was sufficient to increase T-cell adhesion to hepatic epithelial cells. Such an increase depended on the epithelial cell polarity and ICAM-1 expression, showing that the epithelial transcytotic machinery regulates the adhesion of lymphocytes to polarized epithelial cells. Our findings strongly suggest that the polarized intracellular transport of adhesion receptors constitutes a new regulatory layer of the epithelial inflammatory response., The work was supported by grants SAF2017-88187-R and PID2020-119881RB-I00 from AEI (to J.M.) and S2017/BMD-3817 TomoXliver (to J.M., J.M.C and I.C.) and IND2019/BMD-17139 (to J.M.) from Comunidad de Madrid. S.B.F is supported by Endocornea, convenio colaboración CSIC, funded by Instituto de Investigación Fundación Jiménez Díaz. C.C-N. is a recipient of FPI fellowships from MINECO. N.C-A. is a recipient of an FPU fellowship from MECD. N.R-R is additionally supported by funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007–2013) under REA grant agreement n°608765. Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin

  • Cacho-Navas, Cristina
  • López-Pujante, Carmen
  • Reglero-Real, Natalia
  • Colás-Algora, Natalia
  • Cuervo, Ana
  • Conesa, Jose Javier
  • Barroso, Susana
  • de Rivas, Gema
  • Ciordia, Sergio
  • Paradela, Alberto
  • D'Agostino, Gianluca
  • Manzo, Carlo
  • Feito, Jorge
  • Andrés, Germán
  • Molina-Jiménez, Francisca
  • Majano, Pedro
  • Correas, Isabel
  • Carazo, José-Maria
  • Nourshargh, Sussan
  • Huch, Meritxell
  • Millán, Jaime
Epithelial intercellular adhesion molecule (ICAM)-1 is apically polarized, interacts with, and guides leukocytes across epithelial barriers. Polarized hepatic epithelia organize their apical membrane domain into bile canaliculi and ducts, which are not accessible to circulating immune cells but that nevertheless confine most of ICAM-1. Here, by analyzing ICAM-1_KO human hepatic cells, liver organoids from ICAM-1_KO mice and rescue-of-function experiments, we show that ICAM-1 regulates epithelial apicobasal polarity in a leukocyte adhesion-independent manner. ICAM-1 signals to an actomyosin network at the base of canalicular microvilli, thereby controlling the dynamics and size of bile canalicular-like structures. We identified the scaffolding protein EBP50/NHERF1/SLC9A3R1, which connects membrane proteins with the underlying actin cytoskeleton, in the proximity interactome of ICAM-1. EBP50 and ICAM-1 form nano-scale domains that overlap in microvilli, from which ICAM-1 regulates EBP50 nano-organization. Indeed, EBP50 expression is required for ICAM-1-mediated control of BC morphogenesis and actomyosin. Our findings indicate that ICAM-1 regulates the dynamics of epithelial apical membrane domains beyond its role as a heterotypic cell– cell adhesion molecule and reveal potential therapeutic strategies for preserving epithelial architec-ture during inflammatory stress., The work was supported by grants PID2020-119881RB-I00 from AEI (to CC-N, CL-P, NC-A, SB, GdR, JF, and JM) and P2022/BMD-7232 TomoXliver2 (to AC, SB, JMC, and JM), and IND2019/BMD-17139 (to JM) from Comunidad de Madrid. This research work was also funded by the European Commission─NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). SB is supported by Endocornea, Convenio Colaboración CSIC, funded by Instituto de Investigación Fundación Jiménez Díaz. CM acknowledges support through the grant PID2021-125386NB-I00 funded by MCIN/AEI/10.13039/501100011033/and FEDER 'ERDF A way of making Europe'. CC-N is a recipient of FPI fellowships from MINECO. NC-A is a recipient of an FPU fellowship from MECD. NR-R is supported by funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007–2013) under REA grant agreement no. 608765 and also by Ramón y Cajal program, grant RYC2021-031221-I and grant PID2022-137552OA-I00 from AEI